These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 21640052)

  • 1. The potential roles for novel biomarkers in rheumatoid arthritis assessment.
    Mease PJ
    Clin Exp Rheumatol; 2011; 29(3):567-74. PubMed ID: 21640052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vectra DA for the objective measurement of disease activity in patients with rheumatoid arthritis.
    Segurado OG; Sasso EH
    Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-29-34. PubMed ID: 25365086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential impact of monitoring disease activity biomarkers on rheumatoid arthritis outcomes and costs.
    Oderda GM; Lawless GD; Wright GC; Nussbaum SR; Elder R; Kim K; Brixner DI
    Per Med; 2018 Jul; 15(4):291-301. PubMed ID: 29693487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of biomarkers in the management of patients with rheumatoid arthritis.
    Nam J; Villeneuve E; Emery P
    Curr Rheumatol Rep; 2009 Oct; 11(5):371-7. PubMed ID: 19772833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Core management principles in rheumatoid arthritis to help guide managed care professionals.
    Agarwal SK
    J Manag Care Pharm; 2011; 17(9 Suppl B):S03-8. PubMed ID: 22073933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel urinary biomarkers for assessing disease activity and prognosis of rheumatoid arthritis.
    Park YJ; Yoo SA; Hwang D; Cho CS; Kim WU
    Exp Mol Med; 2016 Feb; 48(2):e211. PubMed ID: 26915672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical biomarkers and pathogenic-related cytokines in rheumatoid arthritis.
    Niu X; Chen G
    J Immunol Res; 2014; 2014():698192. PubMed ID: 25215307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in treat-to-target in patients with rheumatoid arthritis versus hypertension and diabetes--consequences for clinical care.
    Castrejón I; Pincus T
    Bull NYU Hosp Jt Dis; 2011; 69(2):104-10. PubMed ID: 22035388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum 14-3-3η is a novel marker that complements current serological measurements to enhance detection of patients with rheumatoid arthritis.
    Maksymowych WP; Naides SJ; Bykerk V; Siminovitch KA; van Schaardenburg D; Boers M; Landewé R; van der Heijde D; Tak PP; Genovese MC; Weinblatt ME; Keystone EC; Zhukov OS; Abolhosn RW; Popov JM; Britsemmer K; van Kuijk AW; Marotta A
    J Rheumatol; 2014 Nov; 41(11):2104-13. PubMed ID: 25128504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving the routine management of rheumatoid arthritis: the value of tight control.
    Mease PJ
    J Rheumatol; 2010 Aug; 37(8):1570-8. PubMed ID: 20595287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers for rheumatoid arthritis: making it personal.
    Lindstrom TM; Robinson WH
    Scand J Clin Lab Invest Suppl; 2010; 242():79-84. PubMed ID: 20515283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifaceted roles of adiponectin in rheumatoid arthritis.
    Liu D; Luo S; Li Z
    Int Immunopharmacol; 2015 Oct; 28(2):1084-90. PubMed ID: 26307192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease activity measures for rheumatoid arthritis.
    Dougados M; Aletaha D; van Riel P
    Clin Exp Rheumatol; 2007; 25(5 Suppl 46):S22-9. PubMed ID: 17977485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a multiplex, 12-biomarker test for rheumatoid arthritis.
    Eastman PS; Manning WC; Qureshi F; Haney D; Cavet G; Alexander C; Hesterberg LK
    J Pharm Biomed Anal; 2012 Nov; 70():415-24. PubMed ID: 22749821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical markers of joint tissue turnover in early rheumatoid arthritis.
    Garnero P; Geusens P; Landewé R
    Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S54-8. PubMed ID: 14969051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory markers in patients with rheumatoid arthritis.
    Shrivastava AK; Singh HV; Raizada A; Singh SK; Pandey A; Singh N; Yadav DS; Sharma H
    Allergol Immunopathol (Madr); 2015; 43(1):81-7. PubMed ID: 24656623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calprotectin (a major S100 leucocyte protein) predicts 10-year radiographic progression in patients with rheumatoid arthritis.
    Hammer HB; Ødegård S; Syversen SW; Landewé R; van der Heijde D; Uhlig T; Mowinckel P; Kvien TK
    Ann Rheum Dis; 2010 Jan; 69(1):150-4. PubMed ID: 19095696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomics, proteomics and metabolomics: their emerging roles in the discovery and validation of rheumatoid arthritis biomarkers.
    Castro-Santos P; Laborde CM; Díaz-Peña R
    Clin Exp Rheumatol; 2015; 33(2):279-86. PubMed ID: 25572119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risk and rheumatoid arthritis--the next step: differentiating true soluble biomarkers of cardiovascular risk from surrogate measures of inflammation.
    Kozera L; Andrews J; Morgan AW
    Rheumatology (Oxford); 2011 Nov; 50(11):1944-54. PubMed ID: 21752870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression.
    Brown AK; Quinn MA; Karim Z; Conaghan PG; Peterfy CG; Hensor E; Wakefield RJ; O'Connor PJ; Emery P
    Arthritis Rheum; 2006 Dec; 54(12):3761-73. PubMed ID: 17133543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.